...
首页> 外文期刊>Journal of Medical Virology >Epstein-Barr virus gene expression and latent membrane protein 1 gene polymorphism in pediatric liver transplant recipients.
【24h】

Epstein-Barr virus gene expression and latent membrane protein 1 gene polymorphism in pediatric liver transplant recipients.

机译:小儿肝移植受者中爱泼斯坦-巴尔病毒基因表达和潜伏膜蛋白1基​​因多态性。

获取原文
获取原文并翻译 | 示例
           

摘要

Immunosuppressed pediatric transplant recipients are at risk of developing Epstein-Barr virus (EBV)-associated complications (such as post-transplant lymphoproliferative disorders). Monitoring of the EBV DNA level in blood alone has a low predictive value for the post-transplant course of EBV infection and its complications. Therefore, additional prognostic markers are widely sought. The study aim was to analyze EBV gene expression patterns and LMP1 polymorphism in relation to EBV DNA levels in pediatric liver transplant recipients. EBV load measurement, LMP1 variant, and gene expression analysis were performed in collected prospectively multiple blood samples from 30 patients. Several distinct patterns of EBV gene expression were identified: latency 2 (71%), latency 3 (13%), latency 0 (11%), and lytic infection (5%). In most children's multiple blood samples, both EBV gene expression patterns and expression levels of individual EBV genes varied significantly over time. EBV gene expression patterns were not associated with the EBV load. However, the viral load correlated with the LMP1 and LMP2 expression (r = 0.34; P = 0.006, and r = 0.45; P = 0.001, respectively). Two variants of the LMP1 gene were detected, and they were consistent over time in individual patients. A wild type of LMP1 was associated with higher EBV-DNA loads (P = 0.03). This indicates that EBV infection in immunosuppressed patients is a very dynamic process, but changes in the state of EBV infection do not influence significantly the viral load. The latter, however, can be associated with the activity of LMP1 and LMP2 genes, as well as polymorphism of LMP1.
机译:免疫抑制的小儿移植受者有发生爱泼斯坦-巴尔病毒(EBV)相关并发症的风险(例如移植后的淋巴增生性疾病)。单独监测血液中的EBV DNA水平对于EBV感染及其并发症的移植后进程具有较低的预测价值。因此,广泛地寻求其他的预后标志物。本研究的目的是分析小儿肝移植受者中EBV基因表达模式和LMP1多态性与EBV DNA水平的关系。 EBV负荷测量,LMP1变异和基因表达分析在30例患者的预期多个血液样本中进行。确定了几种不同的EBV基因表达模式:潜伏期2(71%),潜伏期3(13%),潜伏期0(11%)和溶菌感染(5%)。在大多数儿童的多个血液样本中,EBV基因表达模式和单个EBV基因的表达水平都随时间变化很大。 EBV基因表达模式与EBV负荷无关。但是,病毒载量与LMP1和LMP2表达相关(r = 0.34; P = 0.006; r = 0.45; P = 0.001)。检测到LMP1基因的两个变体,并且在个体患者中随时间推移它们是一致的。野生型LMP1与较高的EBV-DNA载量有关(P = 0.03)。这表明免疫抑制患者的EBV感染是一个非常动态的过程,但是EBV感染状态的变化不会显着影响病毒载量。但是,后者可能与LMP1和LMP2基因的活性以及LMP1的多态性有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号